Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jan 09, 2017

Mylan Acquires Cold-EEZE® Brand to Further Expand OTC Business

Dec 29, 2016

Mylan Launches Generic Concerta® Tablets

Dec 29, 2016

Mylan Launches Generic Cerebyx® Injection

Dec 28, 2016

Mylan Launches Generic Zovia® Tablets

Dec 27, 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data

Dec 16, 2016

Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic

Dec 01, 2016

Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever

Nov 28, 2016

Mylan Signs Sub-license Agreement with the Medicines Patent Pool to Increase Access to Hepatitis C Treatment in Developing Countries

Nov 10, 2016

The Medicines Patent Pool Announces First World Health Organization Prequalification Submissions for Generic Dolutegravir

Nov 09, 2016

Mylan Reports Third Quarter 2016 Results

Pagination

First page
Previous page
…
Page 20
Page 21
Page 22
Page 23
Current page 24
Page 25
Page 26
Page 27
Page 28
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.